The coffee, energy drink, and tea industries are eagerly anticipating the US Food and Drug Administration’s decision on caffeine labeling. Will it be a mere guidance or a binding rule? Where will the FDA recommend placing caffeine content on packaging? Could warning labels be introduced?
In June, the FDA’s Human Foods Program made caffeine labeling a top priority and is working on drafting industry guidance. Claudia Lewis from Venable, a law firm, mentioned that this guidance may cover both packaged foods and beverages, as well as products sold in restaurants or retail settings.
Currently, the FDA requires products containing caffeine to list it in the ingredients, but specifying the amount is not mandatory. Jessica Williams from Registrar Corp stated that any guidance on labeling caffeine would be voluntary unless the FDA decides to make it mandatory, which would involve a lengthy process of public comments and rulemaking.
Any future caffeine labeling guidance or rule is likely to recommend placing information on the back or side of packaging, near the Nutrition Facts Panel. Lewis expressed a preference for a guidance document over a rule, as it could provide valuable information to parents without demonizing caffeine.
The FDA’s focus on caffeine comes amidst concerns about teenagers consuming energy drinks. Lewis shared her personal experience with her daughter and the prevalence of caffeine in seemingly harmless drinks like tea. Williams suggested that the FDA may issue advisory statements cautioning against high-caffeine products for certain groups.
In more positive news, a recent statement from the American Heart Association highlighted the potential cardiovascular benefits of moderate coffee consumption. Drinking up to five cups of caffeinated coffee per day was deemed safe and linked to a reduced risk of certain heart conditions. However, excessive caffeine intake, as seen in energy drinks, may pose risks to cardiovascular health.
While tea has received less research attention compared to coffee, it has also been associated with various heart health benefits. Overall, the FDA’s caffeine labeling decision and ongoing research on the health effects of coffee and tea are crucial topics for consumers and industry professionals alike.
